Laupacis, Andreas. “Evidence and Values: Requirements for Public Reimbursement of Drugs for Rare Diseases- A Case Study in Oncology- Reply”. Journal of Population Therapeutics and Clinical Pharmacology 16, no. 2 (December 8, 2018). Accessed November 19, 2024. https://mail.jptcp.com/index.php/jptcp/article/view/557.